Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.

Tuck CJ, Caminero A, Jiménez Vargas NN, Soltys CL, Jaramillo Polanco JO, Lopez Lopez CD, Constante M, Lourenssen SR, Verdu EF, Muir JG, Lomax AE, Reed DE, Vanner SJ.

Neurogastroenterol Motil. 2019 Oct;31(10):e13675. doi: 10.1111/nmo.13675. Epub 2019 Jul 9.

PMID:
31290223
2.

Correction to: Economic burden of multiple sclerosis in a population with low physical disability.

García-Domínguez JM, Maurino J, Martínez-Ginés ML, Carmona O, Caminero AB, Medrano N, Ruíz-Beato E; W-IMPACT Clinical Investigators.

BMC Public Health. 2019 Jul 8;19(1):909. doi: 10.1186/s12889-019-7275-2.

3.

Metabolism of wheat proteins by intestinal microbes: Implications for wheat related disorders.

Caminero A, Verdu EF.

Gastroenterol Hepatol. 2019 Aug - Sep;42(7):449-457. doi: 10.1016/j.gastrohep.2019.04.001. Epub 2019 Jun 28. Review. English, Spanish.

PMID:
31262542
4.

Celiac disease: should we care about microbes?

Caminero A, Verdu EF.

Am J Physiol Gastrointest Liver Physiol. 2019 Aug 1;317(2):G161-G170. doi: 10.1152/ajpgi.00099.2019. Epub 2019 Jun 12.

PMID:
31188640
5.

Economic burden of multiple sclerosis in a population with low physical disability.

García-Domínguez JM, Maurino J, Martínez-Ginés ML, Carmona O, Caminero AB, Medrano N, Ruíz-Beato E; W-IMPACT Clinical Investigators.

BMC Public Health. 2019 May 20;19(1):609. doi: 10.1186/s12889-019-6907-x. Erratum in: BMC Public Health. 2019 Jul 8;19(1):909.

6.

Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2.

Caminero A, McCarville JL, Galipeau HJ, Deraison C, Bernier SP, Constante M, Rolland C, Meisel M, Murray JA, Yu XB, Alaedini A, Coombes BK, Bercik P, Southward CM, Ruf W, Jabri B, Chirdo FG, Casqueiro J, Surette MG, Vergnolle N, Verdu EF.

Nat Commun. 2019 Mar 13;10(1):1198. doi: 10.1038/s41467-019-09037-9.

7.

Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins.

Caminero A, McCarville JL, Zevallos VF, Pigrau M, Yu XB, Jury J, Galipeau HJ, Clarizio AV, Casqueiro J, Murray JA, Collins SM, Alaedini A, Bercik P, Schuppan D, Verdu EF.

Gastroenterology. 2019 Jun;156(8):2266-2280. doi: 10.1053/j.gastro.2019.02.028. Epub 2019 Feb 22.

PMID:
30802444
8.

Measuring burden in caregivers of people with multiple sclerosis: psychometric properties of the CSI questionnaire.

García-Domínguez JM, Martínez-Ginés ML, Carmona O, Caminero AB, Prefasi D, Maurino J, Ballesteros J; W-IMPACT Clinical Investigators.

Patient Prefer Adherence. 2019 Jan 9;13:101-106. doi: 10.2147/PPA.S180863. eCollection 2019.

9.

Mechanisms by which gut microorganisms influence food sensitivities.

Caminero A, Meisel M, Jabri B, Verdu EF.

Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):7-18. doi: 10.1038/s41575-018-0064-z. Review.

10.

Analysis of the 3H8 antigen of Candida albicans reveals new aspects of the organization of fungal cell wall proteins.

Sentandreu R, Caminero A, Rentería I, León-Ramirez C, González-de-la-Vara L, Valentin-Gomez E, Ruiz-Herrera J.

FEMS Yeast Res. 2018 Jun 1;18(4). doi: 10.1093/femsyr/foy035.

PMID:
29648589
11.

A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor.

McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, Duboux S, Steinmann M, Delley M, Tangyu M, Langella P, Mercenier A, Bergonzelli G, Verdu EF.

Appl Environ Microbiol. 2017 Sep 15;83(19). pii: e01323-17. doi: 10.1128/AEM.01323-17. Print 2017 Oct 1.

12.

Assessment of deep dynamic mechanical sensitivity in individuals with tension-type headache: The dynamic pressure algometry.

Palacios-Ceña M, Wang K, Castaldo M, Guerrero-Peral Á, Caminero AB, Fernández-de-Las-Peñas C, Arendt-Nielsen L.

Eur J Pain. 2017 Sep;21(8):1451-1460. doi: 10.1002/ejp.1065. Epub 2017 Jun 2.

PMID:
28573720
13.

Gluten-degrading bacteria are present in the human small intestine of healthy volunteers and celiac patients.

Herrán AR, Pérez-Andrés J, Caminero A, Nistal E, Vivas S, Ruiz de Morales JM, Casqueiro J.

Res Microbiol. 2017 Sep;168(7):673-684. doi: 10.1016/j.resmic.2017.04.008. Epub 2017 May 16.

PMID:
28526528
14.

How infection can incite sensitivity to food.

Verdu EF, Caminero A.

Science. 2017 Apr 7;356(6333):29-30. doi: 10.1126/science.aan1500. No abstract available.

PMID:
28385972
15.

Predictors of burden and depression among caregivers of relapsing-remitting MS patients in Spain: MS Feeling study.

Meca-Lallana J, Mendibe M, Hernández-Clares R, Caminero AB, Mallada-Frechin J, Dávila-Gonzalez P, Garcés-Redondo M, Gómez M, Millán-Pascual J, Soriano-Hernández G, Amigo-Jorrín Mdel C.

Neurodegener Dis Manag. 2016 Aug;6(4):277-87. doi: 10.2217/nmt-2016-0014. Epub 2016 Aug 2.

PMID:
27480482
16.

Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.

Meca-Lallana J, Hernández L, Caminero AB, Girón JM, Cano-Orgaz A, Carcelén-Gadea M, Muñoz D, Durán-Ferreras E, Martín-Hernández J, Sánchez-de la Rosa R; FATIGA Study Group.

Eur Neurol. 2016;76(1-2):40-7. doi: 10.1159/000447630. Epub 2016 Jul 1.

PMID:
27376845
17.

Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.

Caminero A, Galipeau HJ, McCarville JL, Johnston CW, Bernier SP, Russell AK, Jury J, Herran AR, Casqueiro J, Tye-Din JA, Surette MG, Magarvey NA, Schuppan D, Verdu EF.

Gastroenterology. 2016 Oct;151(4):670-83. doi: 10.1053/j.gastro.2016.06.041. Epub 2016 Jun 30.

PMID:
27373514
18.

Novel perspectives on therapeutic modulation of the gut microbiota.

McCarville JL, Caminero A, Verdu EF.

Therap Adv Gastroenterol. 2016 Jul;9(4):580-93. doi: 10.1177/1756283X16637819. Epub 2016 Apr 4. Review.

19.

The GCA1 gene encodes a glycosidase-like protein in the cell wall of Candida albicans.

Maicas S, Caminero A, Martínez JP, Sentandreu R, Valentín E.

FEMS Yeast Res. 2016 Jun;16(4). pii: fow032. doi: 10.1093/femsyr/fow032. Epub 2016 Apr 5.

PMID:
27189368
20.

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.

Sepúlveda M, Armangué T, Sola-Valls N, Arrambide G, Meca-Lallana JE, Oreja-Guevara C, Mendibe M, Alvarez de Arcaya A, Aladro Y, Casanova B, Olascoaga J, Jiménez-Huete A, Fernández-Fournier M, Ramió-Torrentà L, Cobo-Calvo A, Viñals M, de Andrés C, Meca-Lallana V, Cervelló A, Calles C, Rubio MB, Ramo-Tello C, Caminero A, Munteis E, Antigüedad AR, Blanco Y, Villoslada P, Montalban X, Graus F, Saiz A.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 14;3(3):e225. doi: 10.1212/NXI.0000000000000225. eCollection 2016 Jun.

21.

Study of duodenal bacterial communities by 16S rRNA gene analysis in adults with active celiac disease vs non-celiac disease controls.

Nistal E, Caminero A, Herrán AR, Pérez-Andres J, Vivas S, Ruiz de Morales JM, Sáenz de Miera LE, Casqueiro J.

J Appl Microbiol. 2016 Jun;120(6):1691-700. doi: 10.1111/jam.13111. Epub 2016 Apr 4.

22.

Age-related differences in celiac disease: Specific characteristics of adult presentation.

Vivas S, Vaquero L, Rodríguez-Martín L, Caminero A.

World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):207-12. doi: 10.4292/wjgpt.v6.i4.207. Review.

23.

Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives.

Caminero A, Nistal E, Herrán AR, Pérez-Andrés J, Ferrero MA, Vaquero Ayala L, Vivas S, Ruiz de Morales JM, Albillos SM, Casqueiro FJ.

Br J Nutr. 2015 Oct 28;114(8):1157-67. doi: 10.1017/S0007114515002767.

PMID:
26428276
24.

Pharmacological approaches in celiac disease.

McCarville JL, Caminero A, Verdu EF.

Curr Opin Pharmacol. 2015 Dec;25:7-12. doi: 10.1016/j.coph.2015.09.002. Epub 2015 Sep 27. Review.

PMID:
26414923
25.

Widespread pressure pain hypersensitivity in patients with multiple sclerosis with and without pain as sign of central sensitization.

Fernández-de-Las-Peñas C, Ortega-Santiago R, Ortíz-Gutiérrez R, Caminero AB, Salom-Moreno J, Arendt-Nielsen L.

Clin J Pain. 2015 Jan;31(1):66-72. doi: 10.1097/AJP.0000000000000084.

PMID:
24525905
26.

Identification of Candida albicans wall mannoproteins covalently linked by disulphide and/or alkali-sensitive bridges.

Caminero A, Calvo E, Valentín E, Ruiz-Herrera J, López JA, Sentandreu R.

Yeast. 2014 Apr;31(4):137-44. doi: 10.1002/yea.3003. Epub 2014 Feb 27.

27.

Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease.

Caminero A, Herrán AR, Nistal E, Pérez-Andrés J, Vaquero L, Vivas S, Ruiz de Morales JM, Albillos SM, Casqueiro J.

FEMS Microbiol Ecol. 2014 May;88(2):309-19. doi: 10.1111/1574-6941.12295. Epub 2014 Mar 3.

28.

Coeliac disease screening in first-degree relatives on the basis of biopsy and genetic risk.

Vaquero L, Caminero A, Nuñez A, Hernando M, Iglesias C, Casqueiro J, Vivas S.

Eur J Gastroenterol Hepatol. 2014 Mar;26(3):263-7. doi: 10.1097/MEG.0000000000000020.

PMID:
24300305
29.

Catechol-O-methyltransferase Val158Met polymorphism (rs4680) is associated with pain in multiple sclerosis.

Fernández-de-las-Peñas C, Ambite-Quesada S, Ortíz-Gutiérrez R, Ortega-Santiago R, Gil-Crujera A, Caminero AB.

J Pain. 2013 Dec;14(12):1719-23. doi: 10.1016/j.jpain.2013.09.007. Epub 2013 Sep 28.

PMID:
24290452
30.

TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.

Comabella M, Caminero AB, Malhotra S, Agulló L, Fernández O, Reverter F, Vandenbroeck K, Rodríguez-Antigüedad A, Matesanz F, Izquierdo G, Urcelay E, López-Larios A, Sánchez A, Otero S, Tintoré M, Montalban X.

Neurology. 2013 May 28;80(22):2010-6. doi: 10.1212/WNL.0b013e318294b2d6. Epub 2013 Apr 26.

PMID:
23624563
31.

[Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)].

Lainez-Andres JM, Caminero A, Diaz-Insa S, Gracia-Naya M, Huerta-Villanueva M, Irimia P, Jimenez-Hernandez MD, Leira R, Sanchez del Rio-Gonzalez M.

Rev Neurol. 2013 Feb 1;56(3):143-51. Spanish.

32.

Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!

Alkhawajah MM, Caminero AB, Freeman HJ, Oger JJ.

Mult Scler. 2013 Mar;19(3):259-65. doi: 10.1177/1352458512461393. Epub 2012 Oct 1. Review.

PMID:
23027881
33.

Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients.

Nistal E, Caminero A, Vivas S, Ruiz de Morales JM, Sáenz de Miera LE, Rodríguez-Aparicio LB, Casqueiro J.

Biochimie. 2012 Aug;94(8):1724-9. doi: 10.1016/j.biochi.2012.03.025. Epub 2012 Apr 20.

PMID:
22542995
34.

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.

Tur C, Tintoré M, Vidal-Jordana A, Castilló J, Galán I, Río J, Arrambide G, Comabella M, Arévalo MJ, Horno R, Vicente MJ, Caminero A, Nos C, Sastre-Garriga J, Montalban X.

Mult Scler. 2012 Aug;18(8):1193-6. doi: 10.1177/1352458512439238. Epub 2012 Mar 1.

PMID:
22383232
35.

Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.

Comino I, Real A, Vivas S, Síglez MÁ, Caminero A, Nistal E, Casqueiro J, Rodríguez-Herrera A, Cebolla A, Sousa C.

Am J Clin Nutr. 2012 Mar;95(3):670-7. doi: 10.3945/ajcn.111.026708. Epub 2012 Jan 18.

36.

Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab.

Mulero P, Caminero AB, Neri Crespo MJ, Fernández-Herranz R, Téllez Lara N.

J Neuroimmunol. 2012 Feb 29;243(1-2):103-5. doi: 10.1016/j.jneuroim.2011.12.009. Epub 2012 Jan 5.

PMID:
22226471
37.

Links between headaches and epilepsy: current knowledge and terminology.

Caminero A, Manso-Calderón R.

Neurologia. 2014 Oct;29(8):453-63. doi: 10.1016/j.nrl.2011.10.016. Epub 2012 Jan 2. Review. English, Spanish.

38.

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.

Cantó E, Reverter F, Morcillo-Suárez C, Matesanz F, Fernández O, Izquierdo G, Vandenbroeck K, Rodríguez-Antigüedad A, Urcelay E, Arroyo R, Otaegui D, Olascoaga J, Saiz A, Navarro A, Sanchez A, Domínguez C, Caminero A, Horga A, Tintoré M, Montalban X, Comabella M.

Mult Scler. 2012 Jul;18(7):983-90. doi: 10.1177/1352458511433063. Epub 2011 Dec 19.

PMID:
22183936
39.

Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.

Caminero A, Comabella M, Montalban X.

Clin Exp Immunol. 2011 Dec;166(3):338-45. doi: 10.1111/j.1365-2249.2011.04484.x.

40.

Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease.

Nistal E, Caminero A, Herrán AR, Arias L, Vivas S, de Morales JM, Calleja S, de Miera LE, Arroyo P, Casqueiro J.

Inflamm Bowel Dis. 2012 Apr;18(4):649-56. doi: 10.1002/ibd.21830. Epub 2011 Aug 8.

PMID:
21826768
41.

Sleep disturbances in multiple sclerosis.

Caminero A, Bartolomé M.

J Neurol Sci. 2011 Oct 15;309(1-2):86-91. doi: 10.1016/j.jns.2011.07.015. Epub 2011 Aug 3. Review.

PMID:
21813138
42.

A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity.

Caminero A, Nistal E, Arias L, Vivas S, Comino I, Real A, Sousa C, de Morales JM, Ferrero MA, Rodríguez-Aparicio LB, Casqueiro J.

Eur J Nutr. 2012 Apr;51(3):293-9. doi: 10.1007/s00394-011-0214-3. Epub 2011 Jun 14.

PMID:
21671042
43.

[Migraine as a cerebrovascular risk factor].

Caminero AB, Sánchez Del Río González M.

Neurologia. 2012 Mar;27(2):103-11. doi: 10.1016/j.nrl.2011.03.009. Epub 2011 May 13. Review. Spanish.

44.

Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story.

Caminero A, Comabella M, Montalban X.

J Neuroimmunol. 2011 May;234(1-2):1-6. doi: 10.1016/j.jneuroim.2011.03.004. Epub 2011 Apr 7. Review.

PMID:
21474190
45.

Development of a clinical prediction rule for identifying women with tension-type headache who are likely to achieve short-term success with joint mobilization and muscle trigger point therapy.

Fernández-de-las-Peñas C, Cleland JA, Palomeque-del-Cerro L, Caminero AB, Guillem-Mesado A, Jiménez-García R.

Headache. 2011 Feb;51(2):246-61. doi: 10.1111/j.1526-4610.2010.01789.x. Epub 2010 Nov 4.

PMID:
21054361
46.

Tension-type headache and migraine in multiple sclerosis.

Kister I, Caminero AB, Herbert J, Lipton RB.

Curr Pain Headache Rep. 2010 Dec;14(6):441-8. doi: 10.1007/s11916-010-0143-5. Review.

PMID:
20848239
47.

Secondary hypnic headache or symptomatic nocturnal hypertension? Two case reports.

Caminero AB, Martín J, Sánchez del Río M.

Cephalalgia. 2010 Sep;30(9):1137-9. doi: 10.1111/j.1468-2982.2009.02011.x. Epub 2010 May 26. No abstract available.

PMID:
20713565
48.

Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course.

Kister I, Caminero AB, Monteith TS, Soliman A, Bacon TE, Bacon JH, Kalina JT, Inglese M, Herbert J, Lipton RB.

J Headache Pain. 2010 Oct;11(5):417-25. doi: 10.1007/s10194-010-0237-9. Epub 2010 Jul 13.

49.

Idiopathic ophthalmodynia and idiopathic rhinalgia: two topographic facial pain syndromes.

Pareja JA, Cuadrado ML, Porta-Etessam J, Fernández-de-las-Peñas C, Gili P, Caminero AB, Cebrián JL.

Headache. 2010 Sep;50(8):1286-95. doi: 10.1111/j.1526-4610.2010.01659.x. Epub 2010 Apr 8.

PMID:
20408883
50.

[Zonisamide in the preventive treatment of refractory migraine].

Pascual-Gómez J, Gracia-Naya M, Leira R, Mateos V, Alvaro-González LC, Hernando I, Oterino A, Iglesias--Díez F, Caminero A, García-Moncó JC, Forcea N, Guerrero-Peral AL, Bueno V, Santos-García D, Pérez C, Blanco M, Pego-Reigosa R, Rodríguez R, Mederer-Hengstl S, Pato-Pato A, Sánchez-Herrero J, Maciñeiras-Montero JL, Ortega F, Arias M, Díaz-González M.

Rev Neurol. 2010 Feb 1-15;50(3):129-32. Spanish.

Supplemental Content

Loading ...
Support Center